A functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16

被引:14
|
作者
Arany, I
Grattendick, KJ
Whitehead, WE
Ember, IA
Tyring, SK
机构
[1] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA
[2] Univ Texas, Med Branch, Dept Microbiol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Immunol, Galveston, TX 77555 USA
[4] Univ Pecs, Sch Med, Dept Prevent Med & Public Hlth, H-7643 Pecs, Hungary
[5] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77555 USA
关键词
HPV16; transcription; promoter; enhancer; interferon; IRF-1; IRF-E;
D O I
10.1016/S0042-6822(03)00138-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently identified a new enhancer element (HIRE-1, HPV-Interferon Responsive Element-1) in the upstream regulatory region (URR) of human papillomavirus (HPV) type 16. HIRE-1 is located upstream from and in close proximity to the TATA box. HIRE-1 is 1 nt shorter in its 5' sequence in comparison to a consensus IRF-1 binding site (IRF-E). Gel shift analyses clearly demonstrated that HIRE-1 is capable of binding IRF-1 in response to interferon-gamma (IFN-gamma) treatment. In a reporter system, HIRE-1 stimulated transcription in response to IRF-1 or IFNgamma from both a heterologous or the homologous (p97) promoter in a dose-dependent manner. Mutations in the core binding sequence strongly decreased this enhancer activity. Interestingly, HIRE-1 stimulated transcription in the context of the full URR in a cell-type-specific manner, thereby suggesting the role of other cell-type-specific factors that might counteract with its function. Thus, our results may explain the inconsistent clinical and experimental results observed following IFN treatment of cervical lesions or cells. Also, this new enhancer may have an important function during inflammatory responses against HPV type 16. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 50 条
  • [41] Confirmation of differential binding of Interferon Regulatory Factor-1 (IRF-1) to the functional and HIV disease-influencing-2578 A/G polymorphism in CCL2 Reply
    Wright, E. K., Jr.
    Page, S. H.
    Barber, S. A.
    Clements, J. E.
    GENES AND IMMUNITY, 2009, 10 (02) : 199 - 199
  • [42] Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays
    Connett, JM
    Badri, L
    Giordano, TJ
    Connett, WC
    Doherty, GM
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (10): : 587 - 594
  • [43] THE MURINE INTERFERON REGULATORY FACTOR 1 (IRF-1) IS A NEGATIVE REGULATOR OF CELL-PROLIFERATION
    KIRCHHOFF, S
    KOROMILAS, AE
    HAUSER, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 102 - 102
  • [44] TGF-β1 inhibits IFN-γ-induced expression of interferon regulatory factor-1 (IRF-1) in T cells and macrophages
    Park, IK
    Gorham, JD
    FASEB JOURNAL, 2003, 17 (07): : C315 - C315
  • [45] Splicing variants of interferon regulatory factor (IRF-1) mRNA in human leukemia and activated normal lymphocytes
    He, LZ
    Panayiotidis, P
    Hart, SM
    Mehta, AB
    Hoffbrand, AV
    Ganeshaguru, K
    BLOOD, 1995, 86 (10) : 2910 - 2910
  • [46] An immunosuppressive-retroviral peptide down-regulates interferon regulatory factor-1 (IRF-1) expression in monocytes.
    Takahashi, A
    Haraguchi, S
    James-Yarish, M
    Good, RA
    Day, NK
    FASEB JOURNAL, 1999, 13 (05): : A650 - A650
  • [47] Altered phenotype of dextran sodium sulfate (DSS) colitis in interferon regulatory factor-1 (IRF-1) knockout mice.
    Liu, ZY
    Bourne, P
    Udall, JN
    Mannick, EE
    GASTROENTEROLOGY, 2000, 118 (04) : A349 - A349
  • [48] The interferon-α regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors
    Zhou, Y
    Wang, S
    Gobl, A
    Öberg, K
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 707 - 714
  • [49] Interferon regulatory factor 1 (IRF-1) regulates the expression of inducible NO synthase in renal epithelium.
    Guzman, NJ
    AmoahApraku, B
    Pang, MZ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2272 - A2272
  • [50] DIFFERENTIAL EXPRESSION OF INTERFERON REGULATORY FACTOR-1 (IRF-1), IRF-2, AND INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN GENES IN LIPOPOLYSACCHARIDE (LPS)-RESPONSIVE AND LPS-HYPORESPONSIVE MACROPHAGES
    BARBER, SA
    FULTZ, MJ
    SALKOWSKI, CA
    VOGEL, SN
    INFECTION AND IMMUNITY, 1995, 63 (02) : 601 - 608